News
Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.
Apple has officially released the iOS 26 public beta, following its debut at WWDC 2025. The update brings a major visual ...
A research-based lineup of smart, effective classroom design tips that support deep learning, reduce distraction, and build ...
Kick back in oversize recliners with heated seats and watch the latest blockbuster films — just a short walk from your hotel ...
As someone who can’t function in loud places without some sort of noise dampening, I’ve also tested a variety of headphones ...
The QuietComfort Ultra Headphones cost $449, a whole $100 more than the $349 QuietComfort Headphones. In a vacuum, without ...
August 20th is the date to mark on your calendars if you're a big fan of Google's Pixel smartphones. That's the day the ...
Trendy but never childish, these airbrushed tips have been making the rounds since 2023, retaining their popularity thanks to an easy-to-replicate design and versatile set of colors. This summer, they ...
The FDA cited trial design concerns and lack of substantial evidence in denying approval for Replimune’s biologics license application in advanced melanoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results